4/A//SEC Filing
Plavan Matthew T 4/A
Accession 0001209191-19-047582
CIK 0001469443other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 1:01 PM ET
Size
13.9 KB
Accession
0001209191-19-047582
Insider Transaction Report
Form 4/AAmended
Plavan Matthew T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-08-27$8.93/sh+2,000$17,860→ 7,000 total - Purchase
Common Stock
2019-08-26$8.33/sh+1,000$8,330→ 1,000 total - Purchase
Common Stock
2019-08-26$9.22/sh+1,000$9,220→ 2,000 total - Purchase
Common Stock
2019-08-27$9.30/sh+1,000$9,300→ 4,000 total - Purchase
Common Stock
2019-08-27$9.32/sh+1,000$9,320→ 3,000 total - Purchase
Common Stock
2019-08-27$8.95/sh+1,000$8,950→ 5,000 total - Purchase
Common Stock
2019-08-28$6.88/sh+1,000$6,880→ 8,000 total
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeother
Related Parties
1- filerCIK 0001326765
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 1:01 PM ET
- Size
- 13.9 KB